93 related articles for article (PubMed ID: 11069041)
1. Loss of the TSG101 leucine zipper domain in aggressive non-Hodgkin's lymphomas.
Ferrer M; Hernández S; Campo E; Lazo PA
Leukemia; 2000 Nov; 14(11):2014-6. PubMed ID: 11069041
[No Abstract] [Full Text] [Related]
2. Expression of a new isoform of the tumor susceptibility TSG101 protein lacking a leucine zipper domain in Burkitt lymphoma cell lines.
Ferrer M; López-Borges S; Lazo PA
Oncogene; 1999 Apr; 18(13):2253-9. PubMed ID: 10327071
[TBL] [Abstract][Full Text] [Related]
3. Aberrant expression of TSG101 in Taiwan Chinese breast cancer.
Lo YF; Chen TC; Chen SC; Chao CC
Breast Cancer Res Treat; 2000 Apr; 60(3):259-66. PubMed ID: 10930114
[TBL] [Abstract][Full Text] [Related]
4. Role of ESCRT-I in retroviral budding.
Martin-Serrano J; Zang T; Bieniasz PD
J Virol; 2003 Apr; 77(8):4794-804. PubMed ID: 12663786
[TBL] [Abstract][Full Text] [Related]
5. Stress-induced aberrant splicing of TSG101: association to high tumor grade and p53 status in breast cancers.
Turpin E; Dalle B; de Roquancourt A; Plassa LF; Marty M; Janin A; Beuzard Y; de Thé H
Oncogene; 1999 Dec; 18(54):7834-7. PubMed ID: 10618725
[TBL] [Abstract][Full Text] [Related]
6. Aberrant splicing of the TSG101 tumor suppressor gene in human breast and ovarian cancers.
Carney ME; Maxwell GL; Lancaster JM; Gumbs C; Marks J; Berchuck A; Futreal PA
J Soc Gynecol Investig; 1998; 5(5):281-5. PubMed ID: 9773405
[TBL] [Abstract][Full Text] [Related]
7. A putative tumor suppressor, TSG101, acts as a transcriptional suppressor through its coiled-coil domain.
Watanabe M; Yanagi Y; Masuhiro Y; Yano T; Yoshikawa H; Yanagisawa J; Kato S
Biochem Biophys Res Commun; 1998 Apr; 245(3):900-5. PubMed ID: 9588212
[TBL] [Abstract][Full Text] [Related]
8. A GCN4 variant with a C-terminal basic region binds to DNA with wild-type affinity.
Hollenbeck JJ; Gurnon DG; Fazio GC; Carlson JJ; Oakley MG
Biochemistry; 2001 Nov; 40(46):13833-9. PubMed ID: 11705372
[TBL] [Abstract][Full Text] [Related]
9. Targeted deletion of the Tsg101 gene results in cell cycle arrest at G1/S and p53-independent cell death.
Krempler A; Henry MD; Triplett AA; Wagner KU
J Biol Chem; 2002 Nov; 277(45):43216-23. PubMed ID: 12205095
[TBL] [Abstract][Full Text] [Related]
10. [TSG101 and breast cancer: a correctly named tumor-suppressor gene?].
Bénard J; Ahomadégbé JC
Bull Cancer; 1997 Dec; 84(12):1141-2. PubMed ID: 9587367
[TBL] [Abstract][Full Text] [Related]
11. p53 induction prevents accumulation of aberrant transcripts in cancer cells.
Moyret-Lalle C; Duriez C; Van Kerckhove J; Gilbert C; Wang Q; Puisieux A
Cancer Res; 2001 Jan; 61(2):486-8. PubMed ID: 11212237
[TBL] [Abstract][Full Text] [Related]
12. Reduction of TSG101 protein has a negative impact on tumor cell growth.
Zhu G; Gilchrist R; Borley N; Chng HW; Morgan M; Marshall JF; Camplejohn RS; Muir GH; Hart IR
Int J Cancer; 2004 Apr; 109(4):541-7. PubMed ID: 14991575
[TBL] [Abstract][Full Text] [Related]
13. Identical variant TSG101 transcripts in soft tissue sarcomas and various non-neoplastic tissues.
Willeke F; Ridder R; Bork P; Klaes R; Mechtersheimer G; Schwarzbach M; Zimmer D; Kloor M; Lehnert T; Herfarth C; von Knebel Doeberitz M
Mol Carcinog; 1998 Dec; 23(4):195-200. PubMed ID: 9869447
[TBL] [Abstract][Full Text] [Related]
14. Cloning and expression of human B cell-specific transcription factor BACH2 mapped to chromosome 6q15.
Sasaki S; Ito E; Toki T; Maekawa T; Kanezaki R; Umenai T; Muto A; Nagai H; Kinoshita T; Yamamoto M; Inazawa J; Taketo MM; Nakahata T; Igarashi K; Yokoyama M
Oncogene; 2000 Aug; 19(33):3739-49. PubMed ID: 10949928
[TBL] [Abstract][Full Text] [Related]
15. Truncated TSG101 transcripts in human leukemia and lymphoma cell lines.
Hosokawa Y; Nagai E; Seto M
J Cancer Res Clin Oncol; 2000 Feb; 126(2):79-84. PubMed ID: 10664246
[TBL] [Abstract][Full Text] [Related]
16. Evidence that TSG101 aberrant transcripts are PCR artifacts.
Hampl M; Hampl J; Plaschke J; Fitze G; Schackert G; Saeger HD; Schackert HK
Biochem Biophys Res Commun; 1998 Jul; 248(3):753-60. PubMed ID: 9704000
[TBL] [Abstract][Full Text] [Related]
17. Aberrant splicing of the TSG101 and FHIT genes occurs frequently in multiple malignancies and in normal tissues and mimics alterations previously described in tumours.
Gayther SA; Barski P; Batley SJ; Li L; de Foy KA; Cohen SN; Ponder BA; Caldas C
Oncogene; 1997 Oct; 15(17):2119-26. PubMed ID: 9366528
[TBL] [Abstract][Full Text] [Related]
18. Potential transcription regulatory sequences in a promoter region of the wheat basic/leucine zipper protein HBP-1b(c38) gene.
Mikami K; Katsura MA; Ito T; Iwabuchi M
Plant Cell Physiol; 1995 Oct; 36(7):1375-9. PubMed ID: 8564306
[TBL] [Abstract][Full Text] [Related]
19. Frequent abnormalities of TSG101 transcripts in human prostate cancer.
Sun Z; Pan J; Bubley G; Balk SP
Oncogene; 1997 Dec; 15(25):3121-5. PubMed ID: 9444960
[TBL] [Abstract][Full Text] [Related]
20. Tsg101: a novel tumor susceptibility gene isolated by controlled homozygous functional knockout of allelic loci in mammalian cells.
Li L; Cohen SN
Cell; 1996 May; 85(3):319-29. PubMed ID: 8616888
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
